Tag Archives: COVID drug remdesivir to be priced at $2

Gilead Sciences Inc. said it will charge the U.S. government and other developed countries $390 per vial for its coronavirus-fighting drug remdesivir, or about $2,340 for a typical five-day course of treatment. Gilead said in a statement Monday it would offer this price to developed countries around the world, in order to create a one-price model that would avoid the …

Read More »